Trial Site Detail
Drug: |
Vemurafenib |
|||
|---|---|---|---|---|
Trial: |
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations (AcSé) |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Active, not recruiting |
|||
Hopital Saint-Joseph Service Oncologie |
Principal Investigator: |
Gael Deplanque |
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Hopital Saint-Joseph Service Oncologie Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.